Opal Immunotherapy

· Medicines Development for Global Health

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opal Immunotherapy, covering 2018-03-22 to 2018-03-22. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People [Phase 1]